Home/Filings/4/A/0001628280-21-017225
4/A//SEC Filing

Fair Richard A. 4/A

Accession 0001628280-21-017225

CIK 0001358403other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 12:21 PM ET

Size

5.5 KB

Accession

0001628280-21-017225

Insider Transaction Report

Form 4/AAmended
Period: 2021-08-16
Fair Richard A.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-16+265,000265,000 total
    Exercise: $2.88From: 2022-08-16Exp: 2031-08-16Common Stock (265,000 underlying)
Footnotes (1)
  • [F1]This amendment is being filed to correct the typographical error in the exercise price of the stock option on the original Form 4 filed with the SEC on August 16, 2021

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001695851

Filing Metadata

Form type
4/A
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 12:21 PM ET
Size
5.5 KB